EUVIMEDEUVIMED entdecken
Crossref

Central sleep apnea treated by a constant low-dose CO 2 supplied by a novel device

Yuan-Ming Luo iD, Yong-Yi Chen, Shan-Feng Liang, Lu-Guang Wu, Andrew Wellman, R Doug McEvoy, Joerg Steier, Danny J Eckert iD, Michael I Polkey

Journal of Applied Physiology · 01.11.2023 · 135 (5) · 977-984

DOI: 10.1152/japplphysiol.00312.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Physiology, erschienen am 01.11.2023. Verfasst von Yuan-Ming Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Sleep Apnea, Central, Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Zhongnanshan Medical Foundation of Guangdong Province Grant, Zhongnanshan Medical Foundation of Guangdong Province, Guangdong Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel device using a special mask was developed and proved that CO 2 therapy using the device could eliminate central sleep apnea (CSA) events and improve sleep quality including reducing arousal index in patients with heart failure. The device would become a useful clinical treatment for heart failure patients with CSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, CentralHeart FailureHumansCarbon DioxideSleepContinuous Positive Airway Pressure

Stichwörter der Autor:innen

CO2 inhalationcentral sleep apneaheart failurenovel device

Substanzen

Carbon Dioxide

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.
  • College of Medicine and Public Health, Adelaide Institute for Sleep Health, Flinders University, Adelaide, South Australia, Australia.
  • Lane Fox Respiratory Unit/Sleep Disorders Centre, London, United Kingdom.
  • Royal Brompton Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

ORCID-Profile: Yuan-Ming Luo, Danny J Eckert

Förderung

  • Zhongnanshan Medical Foundation of Guangdong Province Grant
  • Zhongnanshan Medical Foundation of Guangdong Province
  • Guangdong Provincial Department of Science and Technology
  • Guangzhou Municipal Science and Technology Bureau

Zitieren

APA

Luo, Y. M., Chen, Y. Y., Liang, S. F., Wu, L. G., Wellman, A., McEvoy, R. D., Steier, J., Eckert, D. J., & Polkey, M. I. (2023). Central sleep apnea treated by a constant low-dose CO 2 supplied by a novel device. Journal of Applied Physiology, 135(5), 977-984. https://doi.org/10.1152/japplphysiol.00312.2023

Vancouver

Luo YM, Chen YY, Liang SF, Wu LG, Wellman A, McEvoy RD, et al. Central sleep apnea treated by a constant low-dose CO 2 supplied by a novel device. Journal of Applied Physiology. 2023;135(5):977-984. doi:10.1152/japplphysiol.00312.2023

BibTeX
@article{Luo2023,
  author = {Luo, Yuan-Ming and Chen, Yong-Yi and Liang, Shan-Feng and Wu, Lu-Guang and Wellman, Andrew and McEvoy, R Doug and Steier, Joerg and Eckert, Danny J and Polkey, Michael I},
  title = {Central sleep apnea treated by a constant low-dose CO 2 supplied by a novel device},
  journal = {Journal of Applied Physiology},
  year = {2023},
  volume = {135},
  number = {5},
  pages = {977--984},
  doi = {10.1152/japplphysiol.00312.2023}
}
Kostenlos starten →